Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank91
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
12.80%
↑ 100% vs avg
Percentile
P91
Near historical high
Streak
2 qtr
Consecutive growthAccelerating
Average
-9483.82%
Historical baseline
PeriodValue
Q3 202512.80%
Q2 20256.32%
Q1 2025-15.51%
Q4 2024-5.86%
Q3 2024-15.96%
Q2 2024-113787.19%
Q1 202499.86%
Q4 2023-31.29%
Q3 2023-22.40%
Q2 2023-16.23%
Q1 2023-30.43%
Q4 20220.00%